Search for Clinical Trial Results
Hereditary Central Nervous System Demyelinating Diseases - 25 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Oral Glyceryl Triacetate (GTA) in Newborns With Canavan Condition: Canavan Disease Date: 2008-06-18 Interventions:
|
Completed |
Study Name: Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy Condition: Metachromatic Leukodystrophy Date: 2008-05-21 Interventions: Drug: Warfarin Oral administration (QD), variable dosage: patients will undergo blood test for PT/INR at |
Terminated |
Study Name: Open-Label Extension Study of Recombinant Human Arylsulfatase A (HGT-1111) in Late Infantile MLD Condition: Late Infantile Metachromatic Leukodystrophy Date: 2008-05-19 Interventions: Drug: HGT-1111 Patients currently dosed with 100 U/kg or 200 U/kg will continue this treatment. Patients |
Active, not recruiting |
Study Name: The Natural History of Metachromatic Leukodystrophy Condition: Metachromatic Leukodystrophy Date: 2008-03-11 |
Completed |
Study Name: Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD) Condition: Late Infantile Metachromatic Leukodystrophy Date: 2008-02-29 Interventions: Biological: Recombinant human Arylsulfatase A (rhASA) intravenous infusion, every other week for 26 week |